v3.26.1
Share-based payments (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jan. 30, 2026
Jan. 31, 2025
Feb. 02, 2024
Share-based payments      
Number of shares of common stock authorized for grant 11,838,143    
Share-based compensation expense      
Pre-tax $ 91,453 $ 58,738 $ 51,891
Net of tax 70,419 $ 45,933 $ 40,683
Total unrecognized compensation cost $ 112,100    
Expected weighted average expense recognition period (in years) 1 year 8 months 12 days    
Director      
Share-based payments      
Vesting period 1 year    
Stock options      
Weighted average for key assumptions used in determining the fair value      
Expected dividend yield (as a percent) 2.90% 1.60% 1.50%
Expected stock price volatility (as a percent) 35.90% 30.40% 27.70%
Weighted average risk-free interest rate (as a percent) 4.30% 4.10% 4.10%
Expected term of options (years) 5 years 1 month 6 days 4 years 8 months 12 days 4 years 8 months 12 days
Options Issued      
Balance at the beginning of the period (in shares) 2,959,938    
Granted (in shares) 4,421    
Exercised (in shares) (138,611)    
Canceled or expired (in shares) (254,791)    
Balance, at the end of the period (in shares) 2,570,957 2,959,938  
Exercisable at the end of the period (in shares) 1,581,531    
Average Exercise Price      
Balance at the beginning of the period (in dollars per share) $ 160.6    
Granted (in dollars per share) 82.58    
Exercised (in dollars per share) 88.2    
Canceled or expired (in dollars per share) 167.95    
Balance at the end of the period (in dollars per share) 163.64 $ 160.6  
Exercisable at the end of the period (in dollars per share) $ 170.36    
Remaining Contractual Term      
Balance, at the end of the period 5 years 9 months 18 days    
Exercisable at the end of the period 4 years 7 months 6 days    
Intrinsic Value      
Balance at the end of the period $ 23,450    
Exercisable at the end of the period $ 13,649    
Weighted average grant date fair value (in dollars per share) $ 24.16 $ 42.06 $ 44.97
Intrinsic value of options exercised $ 4,700 $ 4,800 $ 19,000
Share-based compensation expense      
Pre-tax 17,287 21,137 19,400
Net of tax $ 13,311 $ 16,529 $ 15,210
Stock options | Employees      
Share-based payments      
Vesting period 4 years    
Performance Stock Units      
Share-based payments      
Vesting period 3 years    
Weighted average grant date fair value of awards issued (in dollars per share) $ 84.08 $ 154.21 $ 208.13
Intrinsic Value      
Balance at the end of the period $ 62,895    
Units Issued      
Awards outstanding at the beginning of the period (in shares or rights) 71,730    
Granted (in shares or rights) 454,393    
Converted to common stock (in shares or rights) (7,651)    
Canceled (in shares or rights) (79,968)    
Awards outstanding at the end of the period (in shares or rights) 438,504 71,730  
Share-based compensation expense      
Pre-tax $ 16,414 $ 970 $ 1,732
Net of tax $ 12,639 $ 759 $ 1,358
Performance Stock Units | Minimum      
Share-based payments      
Performance period 1 year    
Performance Stock Units | Maximum      
Share-based payments      
Performance period 3 years    
Restricted Stock Units      
Share-based payments      
Weighted average grant date fair value of awards issued (in dollars per share) $ 85.11 $ 130.78 $ 193.78
Intrinsic Value      
Balance at the end of the period $ 212,385    
Units Issued      
Awards outstanding at the beginning of the period (in shares or rights) 641,960    
Granted (in shares or rights) 1,264,784    
Converted to common stock (in shares or rights) (208,431)    
Canceled (in shares or rights) (217,557)    
Awards outstanding at the end of the period (in shares or rights) 1,480,756 641,960  
Share-based compensation expense      
Pre-tax $ 57,752 $ 36,631 $ 30,759
Net of tax $ 44,469 $ 28,645 $ 24,115
Restricted Stock Units | Employees      
Share-based payments      
Vesting period 3 years